Abigail Davis, APRN
Nurse Practitioner · Brentwood, TNNPI 1477144459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $941 and has fallen 87.3% since, to $119 in 2025.
Across 127 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$323
- Novo Nordisk$272
- Lilly USA, LLC$201
- Amgen$190
- Novartis$137
- Biohaven Pharmaceutical Holding Company Ltd.$88
- plus $841 from 26 others
What the payments were for
- Food & beverage$2,052100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $323 |
| Novo Nordisk | 15 | $272 |
| Lilly USA, LLC | 15 | $201 |
| Amgen(2 entities) | 6 | $190 |
| Novartis | 8 | $137 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $88 |
| Bayer | 3 | $64 |
| AstraZeneca(2 entities) | 3 | $59 |
| Merck | 4 | $58 |
| Melinta Therapeutics, LLC | 3 | $58 |
| Boehringer Ingelheim | 3 | $52 |
| Abbott | 2 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Insulet Corporation | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Almatica Pharma LLC | 1 | $27 |
| Revance Therapeutics, Inc. | 1 | $27 |
| Genentech USA, Inc. | 5 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $25 |
| Pfizer | 1 | $24 |
| Lundbeck LLC | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Boston Scientific | 1 | $16 |
| GSK | 1 | $16 |
| Eisai Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$125
How this compares
$2,052 in reported general payments places this provider in the 80th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Brentwood
- Angela MoreheadBrentwood$59K
- Abigail JamesBrentwood$58K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$87K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.